slotkoers
Shanghai S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
10,98
CNY
|
+0,64%
|
|
+7,75%
|
+2,33%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
12.793
|
13.033
|
16.368
|
11.203
|
10.281
|
10.484
|
-
|
-
|
Bedrijfswaarde
1 |
12.793
|
13.033
|
16.368
|
11.203
|
10.281
|
10.484
|
10.484
|
10.484
|
K/w-verhouding
|
37,1
x
|
18,1
x
|
15,7
x
|
20,9
x
|
23,8
x
|
22,4
x
|
16,6
x
|
14,3
x
|
Dividendrendement
|
7,49%
|
1,69%
|
1,93%
|
1,45%
|
1,4%
|
1,46%
|
2,09%
|
2,91%
|
Marktkapitalisatie/omzet
|
1,82
x
|
1,78
x
|
1,79
x
|
1,38
x
|
1,32
x
|
1,22
x
|
1,11
x
|
0,99
x
|
Bedrijfswaarde/omzet
|
1,82
x
|
1,78
x
|
1,79
x
|
1,38
x
|
1,32
x
|
1,22
x
|
1,11
x
|
0,99
x
|
Bedrijfswaarde/EBITDA
|
-
|
9,39
x
|
9,26
x
|
9,41
x
|
9,29
x
|
7,25
x
|
5,95
x
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1,64
x
|
1,71
x
|
1,88
x
|
1,22
x
|
1,08
x
|
1,06
x
|
1,01
x
|
0,97
x
|
Aantal aandelen (in duizenden)
|
958.301
|
958.301
|
958.301
|
958.301
|
958.148
|
954.810
|
-
|
-
|
Referentieprijs
2 |
13,35
|
13,60
|
17,08
|
11,69
|
10,73
|
10,98
|
10,98
|
10,98
|
Datum van publicatie
|
23-04-20
|
22-04-21
|
26-04-22
|
25-04-23
|
25-04-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
7.044
|
7.327
|
9.129
|
8.116
|
7.794
|
8.620
|
9.482
|
10.599
|
EBITDA
1 |
-
|
1.388
|
1.767
|
1.190
|
1.107
|
1.446
|
1.763
|
-
|
Bedrijfsresultaat (EBIT)
1 |
409
|
882,6
|
1.179
|
504,6
|
380,2
|
529,5
|
757,5
|
785
|
Operationele Marge
|
5,81%
|
12,05%
|
12,92%
|
6,22%
|
4,88%
|
6,14%
|
7,99%
|
7,41%
|
Resultaat voor belastingen (EBT)
1 |
397,5
|
851
|
1.154
|
491,4
|
363,3
|
521
|
749
|
768
|
Nettowinst (verlies)
1 |
342,8
|
717,4
|
1.045
|
539,6
|
429,6
|
475,6
|
636,8
|
745,6
|
Nettomarge
|
4,87%
|
9,79%
|
11,45%
|
6,65%
|
5,51%
|
5,52%
|
6,72%
|
7,03%
|
WPA
2 |
0,3600
|
0,7500
|
1,090
|
0,5600
|
0,4500
|
0,4900
|
0,6600
|
0,7700
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
1,000
|
0,2300
|
0,3300
|
0,1700
|
0,1500
|
0,1600
|
0,2300
|
0,3200
|
Datum van publicatie
|
23-04-20
|
22-04-21
|
26-04-22
|
25-04-23
|
25-04-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
4,44%
|
9,26%
|
12,6%
|
5,99%
|
4,54%
|
4,83%
|
6,16%
|
6,82%
|
ROA (netto-inkomsten/totale activa)
|
3,36%
|
6,88%
|
9,08%
|
4,32%
|
3,41%
|
2,9%
|
3,85%
|
3,5%
|
Totale activa
1 |
10.205
|
10.432
|
11.516
|
12.483
|
12.606
|
16.400
|
16.541
|
21.303
|
Nettoactief per aandeel
2 |
8,140
|
7,950
|
9,100
|
9,590
|
9,980
|
10,30
|
10,80
|
11,30
|
Cashflow per aandeel
2 |
0,4600
|
1,300
|
1,180
|
0,5400
|
0,6600
|
0,9300
|
1,160
|
0,8900
|
Capex
1 |
571
|
508
|
933
|
969
|
622
|
1.094
|
1.144
|
1.100
|
Capex/omzet
|
8,11%
|
6,93%
|
10,22%
|
11,94%
|
7,99%
|
12,69%
|
12,06%
|
10,38%
|
Datum van publicatie
|
23-04-20
|
22-04-21
|
26-04-22
|
25-04-23
|
25-04-24
|
-
|
-
|
-
|
Laatste slotkoers
10,98
CNY Gemiddelde koersdoel
11
CNY Spread / Gemiddelde doel +0,18% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +2,33% | 1,44 mld. | | +55,32% | 815 mld. | | +44,05% | 641 mld. | | -6,75% | 352 mld. | | +13,56% | 314 mld. | | +10,68% | 303 mld. | | +16,57% | 242 mld. | | +13,31% | 218 mld. | | +8,48% | 168 mld. | | -2,81% | 159 mld. |
Farmaceutische producten - Andere
|